Cas no 53360-18-2 (Pyridine, 2,6-dichloro-3,4,5-trifluoro-)
Pyridine, 2,6-dichloro-3,4,5-trifluoro- Chemical and Physical Properties
Names and Identifiers
-
- Pyridine, 2,6-dichloro-3,4,5-trifluoro-
- SCHEMBL2088817
- 2,6-Dichloro-3,4,5-trifluoropyridine
- 53360-18-2
-
- Inchi: 1S/C5Cl2F3N/c6-4-2(9)1(8)3(10)5(7)11-4
- InChI Key: JQJBUDZBUCSMNW-UHFFFAOYSA-N
- SMILES: C1(Cl)=NC(Cl)=C(F)C(F)=C1F
Computed Properties
- Exact Mass: 200.9359889Da
- Monoisotopic Mass: 200.9359889Da
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 11
- Rotatable Bond Count: 0
- Complexity: 134
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.1
- Topological Polar Surface Area: 12.9?2
Pyridine, 2,6-dichloro-3,4,5-trifluoro- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A029007399-250mg |
2,6-Dichloro-3,4,5-trifluoropyridine |
53360-18-2 | 95% | 250mg |
$1038.80 | 2023-09-01 | |
| Alichem | A029007399-500mg |
2,6-Dichloro-3,4,5-trifluoropyridine |
53360-18-2 | 95% | 500mg |
$1786.10 | 2023-09-01 | |
| Alichem | A029007399-1g |
2,6-Dichloro-3,4,5-trifluoropyridine |
53360-18-2 | 95% | 1g |
$3184.50 | 2023-09-01 | |
| Enamine | BBV-77670728-1.0g |
2,6-dichloro-3,4,5-trifluoropyridine |
53360-18-2 | 95% | 1.0g |
$0.0 | 2023-01-07 |
Pyridine, 2,6-dichloro-3,4,5-trifluoro- Related Literature
-
Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
-
Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
-
David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
-
Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
-
Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
Additional information on Pyridine, 2,6-dichloro-3,4,5-trifluoro-
Pyridine, 2,6-dichloro-3,4,5-trifluoro-
The compound Pyridine, 2,6-dichloro-3,4,5-trifluoro (CAS NO 53360-18-2) is a halogenated pyridine derivative that has garnered significant attention in the fields of organic chemistry and pharmaceutical research. This molecule features a pyridine ring with multiple halogen substituents, specifically two chlorine atoms at positions 2 and 6, and three fluorine atoms at positions 3, 4, and 5. The unique arrangement of these halogens creates a highly functionalized aromatic system that exhibits distinct chemical properties and potential applications.
Pyridines are nitrogen-containing heterocycles known for their stability and versatile reactivity. The presence of multiple halogens in 2,6-dichloro-3,4,5-trifluoro-pyridine introduces additional electronic effects and steric hindrance, making it a valuable building block in organic synthesis. Recent studies have highlighted its potential as an intermediate in the development of bioactive compounds, including those with antimicrobial, antitumor, and neuroprotective properties.
One of the key advantages of Pyridine, 2,6-dichloro-3,4,5-trifluoro is its high chemical stability. The fluorine atoms, being highly electronegative, enhance the compound's resistance to nucleophilic attack, while the chlorine atoms contribute to its solubility in certain organic solvents. This combination of properties makes it a suitable candidate for use in various chemical reactions, such as Suzuki couplings and Buchwald-Hartwig aminations, which are widely employed in drug discovery.
Recent advancements in medicinal chemistry have demonstrated the utility of this compound in the synthesis of complex molecules with potential therapeutic applications. For instance, researchers have explored its role in constructing heterocyclic frameworks that mimic natural product structures. Such efforts are driven by the need to identify novel scaffolds that can modulate biological targets effectively.
Another area of interest is the exploration of 2,6-dichloro-3,4,5-trifluoro-pyridine as a template for designing fluorinated drugs. Fluorinated compounds are known to exhibit enhanced pharmacokinetic properties, including improved bioavailability and reduced clearance rates. These attributes can be particularly beneficial in the development of drugs targeting diseases with high unmet medical needs, such as cancer and central nervous system disorders.
Moreover, the compound's electronic properties make it a promising candidate for applications in materials science. Its electron-deficient pyridine ring could serve as a valuable component in the synthesis of conjugated polymers and coordination complexes, which are explored for their potential use in optoelectronic devices and sensors.
Recent studies have also investigated the environmental impact of Pyridine, 2,6-dichloro-3,4,5-trifluoro. Research has focused on its biodegradability and toxicity profile to assess its suitability for large-scale applications in industrial processes. Understanding these parameters is crucial for ensuring the safe handling and disposal of this compound during manufacturing and research.
In conclusion, Pyridine, 2,6-dichloro-3,4,5-trifluoro (CAS NO 53360-18-2) stands out as a versatile and valuable compound in the realm of organic chemistry and pharmaceutical research. Its unique structural features, combined with its demonstrated reactivity and potential applications, position it as a key player in the development of innovative chemical entities. As research continues to uncover new insights into its properties and uses, this compound is likely to play an increasingly important role in advancing medical science and technology.
53360-18-2 (Pyridine, 2,6-dichloro-3,4,5-trifluoro-) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)